Head-to-head · WeighScore
bmiMD vs Embody
The verdict
bmiMD takes it — 79.2/100 to 76.5/100.
bmiMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Genuinely flat by dose on both molecules and among the cheapest here — but the page opens on a commitment tab, so the first figure a reader sees is not the monthly one.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | bmiMD | Embody |
|---|---|---|
| WeighScore | 79.2/100 | 76.5/100 |
| Grade | C+ | C |
| Scorecard rank | #30 | #54 |
| Semaglutide | $129/mo month-to-month ($99 only on a 12-month plan) | $79/mo (all doses, promotional rate, compounded) |
| Tirzepatide | $179/mo month-to-month ($139 only on a 12-month plan) | $129/mo (all doses, promotional rate, compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #30 · C+
Strengths
- Flat at every dose: 2.5 mg and 15 mg cost the same, so titrating up never raises the bill
- Both compounded semaglutide and tirzepatide on one account, plus a sublingual line
- Every rung of both ladders is published with the total charge beside each per-month figure
- All 50 states
Where it loses points
- The pricing block opens on the 3-Month tab, so the figure a reader meets first is a commitment rate rather than a month
- The cheapest figures, $99 and $139, require $1,188 or $1,668 paid up front for a full year
- A struck-through $228.60 and $349.20 sit above the ladders under a standing LIMITED TIME label, with no published basis
- Neither the compounding pharmacy nor the prescribing group is named on the product pages
Graded #54 · C
Strengths
- Among the lowest flat rates in the compounded segment — $79/mo semaglutide and $129/mo tirzepatide injection at every dose
- Unique compounded oral tirzepatide gum formulation — alternative for patients who prefer not to inject
- Available in all 50 states with no insurance friction
- 24/7 unlimited clinician messaging and dose-adjustment support included
- Medical leadership by Dr. Alan Viglione, board-certified in Internal Medicine
Where it loses points
- The $79 flat rate relies on an auto-applied promo 'locked forever' — list price in the terms is $199/mo and reviewers allege the lock isn't honored
- Compounded only — no FDA-approved brand-name Ozempic, Wegovy, Zepbound, or Mounjaro option
- Pharmacy partners not publicly named — compounding source transparency is limited
- Compounded oral tirzepatide does not have an FDA-approved counterpart, and oral GLP-1 bioavailability remains an active area of clinical debate
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.